(Q35666992)

9 August 2017

1 reference

title

Animal models of type I allergy using recombinant allergens (English)

1 reference

9 August 2017

3

Ursula Wiedermann

1 reference

9 August 2017

Udo Herz

1

1 reference

9 August 2017

Harald Renz

series ordinal

2

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

32

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

271-280

1 reference

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Different methods of local allergen-specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Role of IL-10 in allergen-specific immunotherapy and normal response to allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Induction of tolerance via the respiratory mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Peripheral deletion of antigen-reactive T cells in oral tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

CD4(+) regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The puzzling world of murine T regulatory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Dendritic cells as a tool to induce anergic and regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Sequential development of airway hyperresponsiveness and acute airway obstruction in a mouse model of allergic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Various immunological phenotypes are associated with increased airway responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Interleukin-4 is required for the induction of lung Th2 mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Early phase bronchoconstriction in the mouse requires allergen-specific IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Mouse models of allergic airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The role of CpG dinucleotides in DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

7 January 2021

CpG DNA as a Th1 trigger

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Gee whiz: CpG DNA allergy therapy!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

DNA-based immunotherapeutics for the treatment of allergic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Sensitization of Mice with Olive Pollen Allergen Ole e 1 Induces a Th2 Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Murine allergic respiratory responses to the major house dust mite allergen Der p 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Inhibition of mucosal and systemic T(h)2-type immune responses by intranasal peptides containing a dominant T cell epitope of the allergen Der p 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Inhibition of airway inflammation in rDer f 2-sensitized mice by oral administration of recombinant der f 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Latex antigens induce IgE and eosinophils in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

A murine model of latex allergy-induced airway hyperreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Immunological responses of mice following administration of natural rubber latex proteins by different routes of exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Murine models for natural rubber latex allergy assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Characterization of T cell responses to Hev b 3, an allergen associated with latex allergy in spina bifida patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Antigen-specific T cell tolerance down-regulates mast cell responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The future of antigen-specific immunotherapy of allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Microflora-associated characteristics in faeces from allergic and nonallergic infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Probiotic research: learn from the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

Hypersensitivity reactions after respiratory sensitization: effect of intranasal peptides containing T-cell epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.013

10.1016/J.YMETH.2003.08.013

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference